The Role of Inhaled Corticosteroid in the Management of Chronic Cough

2006 ◽  
Vol 60 (2) ◽  
pp. 221 ◽  
Author(s):  
Kyung-Hun Lee ◽  
Seung Hun Jang ◽  
Jung-Hwa Lee ◽  
Kwang-Seok Eom ◽  
Joon-Woo Bahn ◽  
...  
Keyword(s):  
Chronic Cough ◽  
Inhaled Corticosteroid

Toxocariasis associated with chronic cough in childhood: a longitudinal study in Hungary

2008 ◽  
Vol 82 (4) ◽  
pp. 357-363 ◽  
Author(s):  
O. Bede ◽  
Z. Szénási ◽  
J. Danka ◽  
K. Gyurkovits ◽  
D. Nagy
Keyword(s):  
Chronic Cough ◽  
Toxocara Canis ◽  
Inhaled Corticosteroid ◽  
Cough Variant Asthma ◽  
Eosinophilic Bronchitis ◽  
Eosinophil Cell ◽  
Airway Symptoms ◽  
Intractable Problem ◽  
Positive Effect

AbstractChronic cough lasting 8 weeks or more often seems to be an intractable problem in childhood. Toxocara infection is associated with an increased prevalence of airway symptoms and may be the possible aetiological agent of chronic cough. Of 425 children aged 2–17 years with chronic cough who were investigated for toxocariasis and the distribution of bronchial asthma (BA), cough variant asthma (CVA) and non-asthmatic eosinophilic bronchitis (NAEB), 136 (32%) were seropositive for Toxocara canis antigens. Ninety-three of the 136 were adequately assessed, diagnosed and followed up during 1 year. BA was diagnosed in 40%, CVA in 27% and NAEB in 33% of the children. The eosinophil cell count, serum T. canis IgG levels and symptoms are predictors of the improvement or the decline of the condition. Presuming the aetiopathogenetic role of T. canis in the inflammatory process of chronic cough, we treated the children not only with inhaled corticosteroid (ICS), but also with a 1-week course of anthelminthics. We could significantly decrease the dose of ICS in 23 (62%) of the 37 with BA. The administration of anthelminthics and the avoidance of sensitizers were sufficient for those with NAEB; none needed ICS. ICS therapy could be stopped 2–3 months later in 17 (68%) of the 25 with CVA. We found that 8 of the 25 with CVA (32%) presented asthmatic symptoms at the end of the 1-year period. In Hungary, T. canis may be a potential sensitizer for chronic cough in seropositive children. Deworming therapy will then alleviate the airway symptoms without exacerbation in patients with BA, and have a positive effect on those with NAEB and the majority of those with CVA.

Treatment for Cough: Two Sides to the Story

2017 ◽  
Vol 2 (3) ◽  
pp. 113-118 ◽  
Author(s):  
Bari Hoffman Ruddy ◽  
Mary J. Sandage
Keyword(s):  
Chronic Cough ◽  
The Other ◽  
Behavioral Strategies ◽  
Speech Language Pathologists ◽  
Airway Clearance ◽  
Two Sides

The role of cough is of interest to speech-language pathologists (SLPs) for two seemingly contradictory reasons: chronic, excessive cough and insufficient cough. Evidence supports the role of the SLP in behavioral strategies for both the reduction and/or elimination of chronic cough, as well as the use of pulmonary exercise to realize improved airway clearance in individuals with a weak, insufficient cough. At both ends of this continuum, anchored at one end by too much coughing and the other end anchored by inadequate cough for airway clearance/pulmonary health, the SLP has an important role.

Chronic Cough: Pathology, Causes and the Role of Rhinitis/Rhinosinusitis

2020 ◽  
pp. 429-438
Author(s):  
Hilal Boyacı ◽  
Bilun Gemicioğlu ◽  
Guy Scadding
Keyword(s):  
Chronic Cough

scholarly journals The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management

2010 ◽  
Vol 19 (2) ◽  
pp. 93-103 ◽  
Author(s):  
Douglas W Mapel ◽  
Judith S Hurley ◽  
Anand A Dalal ◽  
Christopher M Blanchette
Keyword(s):  
Inhaled Corticosteroid ◽  
Agonist Therapy ◽  
Long Acting

The role of Fibreoptic Bronchoscopy (FOB) in the evaluation of chronic cough

2017 ◽  
Author(s):  
Muthu Thirumaran ◽  
Akshay Dwarakanath ◽  
Ahsan Iftikhar ◽  
Louise Flint
Keyword(s):  
Chronic Cough ◽  
Fibreoptic Bronchoscopy

Tu1128 Chronic Cough and Gastroesophageal Reflux Disease : the Role of Microaspiraton

2012 ◽  
Vol 142 (5) ◽  
pp. S-754
Author(s):  
Pelin Ozdemir ◽  
Munevver Erdinc ◽  
Rukiye Vardar ◽  
Ali Veral ◽  
Serhat Bor
Keyword(s):  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Chronic Cough

OC.02.2 REFLUX PATTERN AND ROLE OF IMPEDANCE-PH VARIABLES IN PREDICTING PPI RESPONSE IN PATIENTS WITH SUSPECTED GERD-RELATED CHRONIC COUGH

2014 ◽  
Vol 46 ◽  
pp. S7 ◽  
Author(s):  
M. Ribolsi ◽  
E. Savarino ◽  
N. De Bortoli ◽  
P. Balestrieri ◽  
M. Furnari ◽  
...  
Keyword(s):  
Chronic Cough

scholarly journals THE ROLE OF NEBULIZED BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF BRONCHIAL ASTHMA

2013 ◽  
Vol 10 (6) ◽  
pp. 41-50
Author(s):  
S N Avdeev
Keyword(s):  
Bronchial Asthma ◽  
Beclomethasone Dipropionate ◽  
Inhalation Therapy ◽  
Controlled Trials ◽  
Portable Devices ◽  
Efficacy And Safety ◽  
Inhaled Corticosteroid ◽  
Randomized Controlled ◽  
Steroid Dependent

Beclomethasone dipropionate (BDP, Clenil UDV) is a well-studied inhaled corticosteroid for the treatment of patients with bronchial asthma (BA). Randomized controlled trials have shown that nebulized therapy with BDP was similar in its efficacy and safety to inhalation therapy with budesonide or fluticasone. Preferred patients for the treatment with nebulized BDP are elderly patients with asthma, unable to correctly perform inhalation with portable devices, patients with steroid-dependent asthma, and patients with a temporary loss of asthma control.

Sign in / Sign up

Export Citation Format

Share Document